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orchestrate the local liberation of
additional heme (and other nutrients)
by modulating the expression of viru-
lence factors involved in animal tissue
necrosis or degradation.
Heme may seem an unlikely candi-
date for a specific molecular marker
of a mammalian environment. Hemes
are nearly ubiquitous among organ-
isms in all kingdoms, serving as cofac-
tors in proteins with various cellular
functions relevant to redox, such as
storing oxygen, producing peroxides,
and passing electrons to acceptor
molecules. While the heme porphyrin
ring can be modified with various
side chains, the majority of heme
structures are identical across diverse
species, from mammals to most bac-
teria. Thus, it may be heme concentra-
tion, and not simply its presence, that
serves as an important signal of a
mammalian tissue permissive for in-
fection, unlike the environmental mi-
lieu of many bacteria. The fact that
heme structures are generally well
conserved raises the possibility that
heme recognition originally existed
either as a mechanism for locating
rich sources of iron (and in an easily
assimilated form) in iron-poor environ-
ments, as a way to locate other cells,
or both, eventually evolving into a
mechanism for recognition of eukary-
otic host environments (see Figure 1).
In this sense, heme can be viewed as
analogous to antimicrobial peptides,
which are also produced by very di-
verse organisms, and which are spe-
cifically recognized by bacteria, with
consequent regulation of virulence
properties (Bader et al., 2005).
The work presented here by Torres
et al. implicates heme as a key coordi-
nate regulator of Gram-positive bacte-
rial virulence, in particular because Hss
is so well conserved among diverse
Gram-positive bacteria. This study pro-
vides amplemotivation for further defin-
ing the biochemical properties of the
Hss sensor kinase, as well as its role
in microbial physiology and virulence.
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Antibodies, although critical for host defense against West Nile virus (WNV), can both neutralize and
enhance viral infection. In this issue of Cell Host & Microbe, Pierson et al. dissect these opposing
effects and demonstrate that, when 120 epitopes are available per WNV virion, 25 are occupied
by antibody at 50% neutralization. At lower occupancies, enhancement of infection dominates; at
higher ones, neutralization ensues. These results are important for WNV vaccine design and for
potential therapeutic use of antibodies to WNV.West Nile virus (WNV), a mosquito-
borne flavivirus that has recently
spread to the Americas, causes a
febrile illness that can lead to lethal
encephalitis, particularly among infants,
the elderly, and the immunocompro-mised. Animal model studies show
that antibodies are crucial in host pro-
tection against WNV, and there is a
strong correlation between antibody-
mediated protection in vivo and
neutralization in vitro. However, anti-Cell Host & Micrbodies can also enhance WNV infec-
tivity in vitro (Diamond et al., 2003). In
this issue, Pierson et al. (2007) investi-
gate the stoichiometry both of antibody
neutralization of WNV and of the con-
trasting ability of antibody to enhanceobe 1, April 2007 ª2007 Elsevier Inc. 87
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PreviewsFigure 1. Antibody Number in Virus Neutralization
The number of IgGmolecules required to neutralize various different viruses is plotted on the y axis
as a function of the estimated surface area of the virion on the x axis. The data points in red rep-
resent previously analyzed viruses (Parren and Burton, 2001 and references therein; the variability
in virion size has not been reproduced): (1) phage MS2, (2) poliovirus, (3) papillomavirus, (4) influ-
enza virus A, and (5) rabies virus. The data point in blue (6) represents neutralization of WNV virions
carrying mixtures of antigenic and nonantigenic E protein and an excess of the nAb E24 (Pierson
et al., 2007). Largely compatible neutralizing occupancies calculated from Kd and half-maximal in-
hibitory nAb concentrations were obtained for the nAbs E16 and E47. The other nAbs studied (E9,
E22, and E49) may require higher occupancies for neutralization, as discussed in the text. Data
points 2, 4, 5, and 6 correspond to 63% neutralization; 3 represents 50% neutralization by
a nAb #9 binding monovalently to papillomavirus; 1 is based on an approximate neutralizing
dose of nAb. The curve is a linear correlation for the anti-log values with r2 = 0.95.WNV infection. In elegant studies, the
authors show that multiple antibody
molecules bound to WNV are required
for neutralization but that the precise
number depends upon the antibody
under study. They further show that
single monoclonal neutralizing anti-
bodies (nAbs) to a given epitope can
mediate both neutralization and en-
hancement under differing conditions.
The dominant effect depends on how
many nAbmolecules bind to the virion.
The main target for nAbs to WNV
is the dimeric E protein, a type II
transmembrane protein, icosahedrally
organized in the viral envelope. The E
protein binds to receptors on target
cells and, after internalization of virions,
triggers fusion of viral and endosomal
membranes. Neutralization epitopes
map to all three domains of E, which
have distinct functions. nAbs to the
lateral face of domain III (DIII) are the
most potent. The structural basis for
the binding of one such nAb, E16,
has been described at the level both
of the E dimer and of the virion88 Cell Host & Microbe 1, April 2007 ª20(Nybakken et al., 2005). E16 blocks
a postattachment step in entry (Ny-
bakken et al., 2005), directly interfering
with fusion; it does not require cross-
linking of two adjacent E proteins. In
the current work, the E16 nAb was
compared with several other nAbs
also directed to DIII, some to overlap-
ping epitopes but differing in potency
and effectiveness of neutralization.
Two approaches helped elucidate the
stoichiometry of neutralization for this
panel of nAbs, i.e., the relationship be-
tween nAb concentration, occupancy
on virions, and the resulting degree of
neutralization (Klasse and Sattentau,
2002; Parren and Burton, 2001).
In the first approach, Kds of nAb
binding to virus particles were esti-
mated by ELISA. This allowed an
approximation of the amount of nAb
bound to virus, i.e., the occupancy of
epitopes on virus particles at defined
levels of neutralization. When the nAb
E16 is used, only 120 of the 180 epi-
topes are available for antibody bind-
ing because of steric hindrance of the07 Elsevier Inc.epitopes closest to a 5-fold axis of
symmetry on the virion. The authors
found that, at 50% neutralization,
about 22% of available E16 epitopes
are occupied by nAb. That is the equiv-
alent of 27 IgG molecules binding
monovalently. How does this compare
with neutralization of other viruses?
Neutralization has been suggested to
result, at least for some viruses, from
antibody coating of the virions. It was
noted that neutralization of a number
of viruses correlated with a roughly
similar density of coating (Parren and
Burton, 2001). Interestingly, given a
flavirus virion diameter of 50 nm, this
model predicts neutralization of WNV
at occupancies that fit those observed
by Pierson at al. (see Figure 1).
Some other nAbs did not conform,
at first glance, to the predictions of
the simple coating model, as they
appeared to require a higher degree
of relative occupancy than E16 to
achieve the same degree of neutrali-
zation. However, the authors point
out some pertinent complications.
The maximum degree of neutralization
also differed between the nAbs; at
least for one nAb (E22), a focus on
only the neutralization-sensitive frac-
tion of virus brings the predicted occu-
pancy at EC50 closer to that of E16.
Further, the authors have evidence
that for some nAbs, as for E16, all
180 copies of the epitope may not be
simultaneously accessible. Molecular
models suggest that some of the epi-
topes are less accessible on the virion
surface than others. If fewer epitopes
can be bound by Ab at saturation
(Bmax), a higher relative occupancy of
the accessible ones would be required
to achieve a given occupancy on the
total number of E antigens and thereby
neutralization. The nAb E9 may have
such a low epitope accessibility that
neutralization requires near saturation
binding. In addition, the estimation
of Kd is fairly imprecise and may be
somewhat inaccurate: virions in ELISA
wells may be distorted, they may
poorly represent infectious virions,
and there may be conformers of E,
only some of which function in entry
and are therefore the most relevant for
predicting the neutralizing occupancy.
Theseexplanations aside, there is an
intriguing hint from this paper that
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what different coating levels on virions.
Indeed, we have observed a similar
phenomenon for HIV-1 neutralization.
How might this arise? One possibility
may lie in the kinetics of nAb binding.
The kinetic binding constants may
influence competitive access of nAbs
and cellular surface factors to the cru-
cial virion sites. Possibly, the precise
location of the epitope and binding
angle of the nAbmaymodulate the ste-
ric hindrance caused and thereby the
ensuing degree of neutralization. To
bring this into context, it can be noted
that, at EC50, the cumulative E16
footprint area was only 6%of the virion
surface (Pierson et al., 2007). But the
bound nAbs, because of their bulk
and the rotational flexibility of their Fc
regions, would occlude a much larger
area (Parren and Burton, 2001).
The second approach to dissect-
ing the stoichiometry of neutralization
used virions with phenotypically mixed
antigenic and nonantigenic E protein
and found neutralizing occupancies
similar to those predicted for nAb E16
(Figure 1). Virions with mixed E protein
were neutralized to 50% by an excess
of nAb E24 when 20% of E was anti-
genic. This translates into approxi-
mately 24 monovalently bound IgG
molecules per virion at 50%neutraliza-
tion. Furthermore, the EC50 values for
virions with increasing proportions of
nonantigenic E shifted upwards, which
is consistent with a roughly constant
neutralization threshold. It also illus-
trates that, when Bmax is reduced (by
mixing in nonantigenicE), neutralization
requires increased relative occupancy
on the remaining antigenic epitopes.
The approaches applied to neutrali-
zation stoichiometry were also applied
to dissecting the stoichiometry of
antibody-dependent enhancement of
infectivity (ADE). Meticulous nAb titra-
tions and experiments using pheno-typic mixing of antigenic with nonanti-
genic E were carried out. Furthermore,
the use of cell lines expressing either
Fcg receptors (FcRs) or the viral at-
tachment receptor DC-SIGN, or both,
and of a mutant form of nAb E16 that
does not interact with FcRs, provided
clear evidence for a strong depen-
dence of ADE on the binding of virus-
Ab complexes to FcRs. The peak of
ADE occurred at Ab occupancies
close to the EC50 of neutralization,
i.e., with approximately 25 IgG mole-
cules bound. Such predicted occu-
pancies are averages, and the sub-
populations of virions that are mainly
enhanced ormainly blockedmay plau-
sibly differ in their mean occupancies.
By mixing the mutant and wild-type
nAb, the authors found that an occu-
pancy of more than approximately 15
epitopes by an ADE-competent nAb
gives significant enhancement. But
there is also an upper limit: although
the molecular mechanism of viral entry
in FcR-enhanced infection may differ
from classical entry, FcR-mediated
infection does not seem to allow a high
degree of occupancy. ADE at sub-
neutralizing concentrations has been
described for several viruses. It can
occur through FcR- and complement-
dependent and -independent mech-
anisms (Klasse and Sattentau, 2002;
Parren and Burton, 2001). The over-
lap between neutralizing and enhanc-
ing concentrations of nAbs against
dengue virus (Morens et al., 1987) is
roughly similar to what is now found
for WNV. The finding that the peak of
ADE occurs at the midpoint of neu-
tralization poses a challenge to vac-
cine development and therapy. Not
only are the antibodies involved in
either effect largely inseparable, but
the effects occur in overlapping con-
centration zones. Only at the highest
occupancies would neutralization
safely dominate.Cell Host & MicNo WNV vaccine or specific treat-
ment exists. As the current work
implies, epitopes that saturate below
the minimal occupancies required for
strong neutralization should if possi-
ble be excluded from immunogens.
In therapy, nAbs that do not bind to
FcRs would be advantageous. The
beneficial net effects of nAbs to
epitopes that are accessible in high
numberswill dependonhow far the an-
tibody concentrations achieved in vivo
exceed the Kds for antibody binding to
virions. The newquantitative insights in
this paper highlight salient questions:
in a population of vaccinees, will the
poorest responders be worse off than
without vaccination? Is neutralization
in vivo by necessity dented by con-
comitant enhancement, particularly
in pathogenically important compart-
ments with low nAb concentrations,
such as the CNS? Perhaps vaccine
research should seek epitopes that
mediate neutralization but not ADE
(although the current work suggests
that such epitopes may not exist)
and/or try to elicit antibody responses,
such as IgM, that would not lead to
FcR-mediated enhancement.
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